Business Wire

Thales’ FlytEDGE Digitally Remasters the inflight Entertainment Experience

28.5.2024 13:00:00 EEST | Business Wire | Press release

Share

Thales unveils FlytEDGE, a revolutionary connected cloud-based inflight entertainment system that will transform passenger engagement to the extraordinary. FlytEDGE is not like a traditional IFE system — with a sleek architecture, cutting-edge features, and unparalleled performance it enables airlines to stand out by bringing the ‘cool’ factor to each seat, offering fully-tailored passenger interactions:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240528532879/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Thales)

  • Live personalization for a journey filled with unique experiences
  • Instantly stream favorites and never miss a beat, continue watching on all flights
  • Immense volume of content to immerse passengers in a world of entertainment choices

Creating personalized experiences

Personalization is at the heart of FlytEDGE. Every passenger is one-of-a-kind and the system empowers airlines to recommend experiences tailored to each person's preferences. FlytEDGE is a true engagement platform offering boundless opportunities for connected and custom journeys. FlytEDGE delivers ‘just-for-you’ experiences never seen before. The system intelligently recommends content across domains, with an individually tailored and immersive entertainment experience.

Delivering the future of entertainment to each passenger

FlytEDGE is the IFEC industry’s first solution to feature edge caching. Passengers can now instantly stream their favorite entertainment using their personal video subscriptions and continue watching their favorite shows from the ground to the air and across flights.

Leveraging a state-of-the-art connected cloud architecture, the system breaks through barriers providing airlines with unparalleled flexibility to rapidly bring in any web-based service.

  • Top game providers for interactive options that will captivate from take-off to touch down
  • Video streamers that go beyond the blockbuster to bring infinite bingeable choices to passengers

With FlytEDGE airlines can integrate partners at the speed of consumer technology to create exhilarating experiences at the forefront of inflight entertainment.

Thales’ FlytEDGE solution features the best consumer technologies on the market. The system boasts cinematic 4K QLED HDR seatback displays to immerse passengers with over 1 billon vibrant colors and two Bluetooth® connections so passengers can pair their personal wireless devices. The system broadcasts the same user interface onboard for all devices- phones, tablets and seatback screens. With Thales’ Crystal Cabin® award-winning power solution delivering high-speed charging at each seat to any passenger device, everyone arrives at their destination recharged, entertained, and relaxed.

Value for airline customers

FlytEDGE features the Crystal Cabin® award-winning Onboard Data Center (ODC) with 96TB of storage to enable on-board edge caching, this solution reduces connectivity consumption and ensures bandwidth is available for other inflight services. No matter how many people watch the same content, each title streams once to the aircraft allowing passengers to instantly access endless entertainment.

The ODC takes the IFE system performance to new heights.

  • Replaces the traditional multi-server network with an effective and compact blade architecture
  • Simplifies upgradeability path with easy blade swaps
  • Ensures the highest system availability

FlytEDGE goes beyond the hardware by redefining software and content updates to reduce cost and lead-time.

  • Exceptional Efficiency – Remote operations with virtual labs for anywhere, anytime updates
  • Superior Performance – Real-time system monitoring and automated maintenance tasks
  • Scalable and Evolving – Continuous integration of new services for a system that is always growing at the speed of consumer technologies

FlytEDGE is already flying! We’re just at the beginning of what’s possible with a fully connected cloud platform. FlytEDGE’s game-changing features and intuitive functionality sets it light-years ahead of the competition. Bringing Thales’ FlytEDGE technology to the airline industry means an in-flight experience that is as eagerly awaited as the destination itself, and there’s so much more to look forward to. It is time to embrace the EDGE.

“At Thales we’re always at the forefront of innovation, investing in digital technologies, and working with our partners to redefine the inflight experience. We’re delighted to bring FlytEDGE’s state-of-the-art capabilities to our airline customers to create memorable and fully-tailored passenger interactions.” said Yannick Assouad, Executive Vice-President Avionics, Thales. “FlytEDGE is the first connected cloud-based IFE to introduce ground-breaking new experiences with a true engagement platform offering boundless opportunities for unique journeys. Stay tuned for more exciting news as the system is set to premier on a leading global airline.”

About Thales

Thales (Euronext Paris: HO) is a global leader in advanced technologies within three domains: Defence & Security, Aeronautics & Space, and Cybersecurity and Digital Identity. It develops products and solutions that help make the world safer, greener and more inclusive.

The Group invests close to €4 billion a year in Research & Development, particularly in key innovation areas such as AI, cybersecurity, quantum technologies, cloud technologies and 6G.

Thales has 81,000* employees in 68 countries. In 2023, the Group generated sales of €18.4 billion.

* These figures exclude the ground transportation business, which is being divested

PLEASE VISIT

Thales Group
Thales InFlyt Experience
X @Thalesgroup

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PRESS CONTACTS
Thales, Media Relations
Head of Media Relations, Aeronautics & Defense
Alice Pruvot
+33 (0)7 70 2711 37
alice.pruvot@thalesgroup.com

Thales, Media Relations
Civil Aeronautics
Chrystelle Dugimont
+33 (0)6 25 15 72 93
chrystelle.dugimont@thalesgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release

IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye